Key facts
- Notable investors include Shenzhen Capital Group, Shenzhen Nanshan Strategic Emerging Industry Investment, Tainuo (Shenzhen) Private Equity Fund Management.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Gate Chip Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Gate Chip Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Gate Chip Biotechnology
Manufacturer of protein detection instruments intended to advance biomedical research and experimental development. The company offers crystal tube-based detection technology, precision imaging systems, and specialized proteomics equipment, enabling scientific institutions and medical researchers to achieve higher accuracy and efficiency in protein analysis.
- Sector
- Healthcare
- HQ
- Shenzhen, China
- Founded
- 2023
- Ownership
- Privately Held (backing)
Gate Chip Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Gate Chip Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Gate Chip Biotechnology in its N-PORT filings yet. We sweep new filings monthly.